EE200200350A - Ühend ja meetod valu raviks - Google Patents

Ühend ja meetod valu raviks

Info

Publication number
EE200200350A
EE200200350A EEP200200350A EEP200200350A EE200200350A EE 200200350 A EE200200350 A EE 200200350A EE P200200350 A EEP200200350 A EE P200200350A EE P200200350 A EEP200200350 A EE P200200350A EE 200200350 A EE200200350 A EE 200200350A
Authority
EE
Estonia
Prior art keywords
compound
treating pain
pain
treating
Prior art date
Application number
EEP200200350A
Other languages
English (en)
Estonian (et)
Inventor
Michael Bare Thomas
Gordon Brown Dean
Murphy Megan
Ann Urbanek Rebecca
Xiao Wenhua
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200350A publication Critical patent/EE200200350A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200200350A 1999-12-23 2000-12-19 Ühend ja meetod valu raviks EE200200350A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23678300P 2000-09-29 2000-09-29
PCT/SE2000/002611 WO2001047927A1 (en) 1999-12-23 2000-12-19 Compound and method for the treatment of pain

Publications (1)

Publication Number Publication Date
EE200200350A true EE200200350A (et) 2003-10-15

Family

ID=26867555

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200350A EE200200350A (et) 1999-12-23 2000-12-19 Ühend ja meetod valu raviks

Country Status (29)

Country Link
EP (1) EP1244662B1 (cs)
JP (1) JP2003519149A (cs)
KR (1) KR20020062369A (cs)
CN (1) CN1188413C (cs)
AR (1) AR027037A1 (cs)
AT (1) ATE294177T1 (cs)
AU (1) AU779703B2 (cs)
BG (1) BG106831A (cs)
BR (1) BR0016654A (cs)
CA (1) CA2394888A1 (cs)
CO (1) CO5271689A1 (cs)
CZ (1) CZ296877B6 (cs)
DE (1) DE60019807T2 (cs)
DK (1) DK1244662T3 (cs)
EE (1) EE200200350A (cs)
ES (1) ES2239632T3 (cs)
HK (1) HK1048811B (cs)
HU (1) HUP0300313A3 (cs)
IL (1) IL150208A0 (cs)
IS (1) IS6427A (cs)
MX (1) MXPA02006155A (cs)
MY (1) MY133596A (cs)
NO (1) NO20022984L (cs)
NZ (1) NZ519390A (cs)
PL (1) PL356664A1 (cs)
PT (1) PT1244662E (cs)
RU (1) RU2234507C2 (cs)
SK (1) SK8792002A3 (cs)
WO (1) WO2001047927A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process
EP2074992B1 (en) * 2005-04-08 2015-05-20 Abbott Laboratories Oral pharmaceutical formulations comprising salts of fenofibric acid
JP5790533B2 (ja) * 2012-02-14 2015-10-07 住友化学株式会社 フェニルヒドラジン−β−カルボキシレート化合物の精製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) * 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
MY133596A (en) 2007-11-30
RU2234507C2 (ru) 2004-08-20
KR20020062369A (ko) 2002-07-25
CA2394888A1 (en) 2001-07-05
CZ20022177A3 (cs) 2002-11-13
AU2420301A (en) 2001-07-09
CN1188413C (zh) 2005-02-09
NZ519390A (en) 2003-07-25
NO20022984D0 (no) 2002-06-20
WO2001047927A1 (en) 2001-07-05
EP1244662B1 (en) 2005-04-27
HUP0300313A2 (hu) 2003-06-28
IL150208A0 (en) 2002-12-01
EP1244662A1 (en) 2002-10-02
NO20022984L (no) 2002-08-20
IS6427A (is) 2002-06-19
CZ296877B6 (cs) 2006-07-12
CN1411459A (zh) 2003-04-16
HK1048811A1 (en) 2003-04-17
DE60019807D1 (de) 2005-06-02
JP2003519149A (ja) 2003-06-17
AU779703B2 (en) 2005-02-10
DK1244662T3 (da) 2005-07-11
BG106831A (en) 2003-03-31
MXPA02006155A (es) 2002-12-05
AR027037A1 (es) 2003-03-12
HUP0300313A3 (en) 2007-05-02
DE60019807T2 (de) 2006-01-19
PT1244662E (pt) 2005-07-29
ES2239632T3 (es) 2005-10-01
BR0016654A (pt) 2002-09-03
ATE294177T1 (de) 2005-05-15
SK8792002A3 (en) 2003-05-02
PL356664A1 (en) 2004-06-28
CO5271689A1 (es) 2003-04-30
HK1048811B (en) 2005-09-30

Similar Documents

Publication Publication Date Title
FI20000863L (fi) Uusi hoitomenetelmä
EE200200242A (et) Meetod suhkurtõve raviks
ID30025A (id) Metode perlakuan tekstil
FI981595A7 (fi) Menetelmä ja laite lumemagneettistimulaation tuottamiseksi
DE60031119D1 (de) Richtbohrvorrichtung und -verfahren
EP1200086A4 (en) THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
ID30339A (id) Metode pengobatan baru
FI991327A7 (fi) Järjestely ja menetelmä kappaleen käärinnän yhteydessä
FI990780L (fi) Menetelmä ja järjestely aineen pumppaamiseksi
IL154225A0 (en) Method for treating ammonia-containing organic waste
FI19992807L (fi) Menetelmä ja järjestely häiriön poistamiseksi
ID19570A (id) Metode merawat tanaman kotiledonous
DE69920224D1 (de) Harnstoffderivate zur Schmerzbekämpfung
EE200200350A (et) Ühend ja meetod valu raviks
FI990973A7 (fi) Harvesteripää ja menetelmä siinä
EE200100710A (et) Meetod ja seade graanulite valmistamiseks
ID16924A (id) Metode perlakuan poliolefin
EE200000074A (et) Meetod ja seade jäätmete töötlemiseks
FI19992294L (fi) Järjestely ja menetelmä sanan pituuden rajoittamiseksi
FI19992817L (fi) Rakennustekninen menetelmä ja laite
DE69936533D1 (de) Neue behandlungsmethode
FI20001913A7 (fi) Menetelmä ja järjestely häiriön vähentämiseksi
FI19992288L (fi) Menetelmä ja laitteisto kasvun tehostamiseksi
SE9802791D0 (sv) Behandlingsmetod
ID26641A (id) Metoda pengobatan